Jenburkt Pharmaceuticals Ltd vs Pentokey Organy India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1150 as of 06 May 15:30 . The P/E Ratio of Jenburkt Pharmaceuticals Ltd changed from 11.1 on March 2021 to 13.9 on March 2025 . This represents a CAGR of 4.60% over 5 yearsThe P/E Ratio of Pentokey Organy (India) Ltd changed from 8.2 on March 2023 to 81.2 on March 2025 . This represents a CAGR of 114.74% over 3 years The Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 182.84 crore on March 2021 to ₹ 446.49 crore on March 2025 . This represents a CAGR of 19.55% over 5 yearsThe Market Cap of Pentokey Organy (India) Ltd changed from ₹ 6.83 crore on March 2021 to ₹ 19.84 crore on March 2025 . This represents a CAGR of 23.77% over 5 years The revenue of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 48.98 crore as compare to the Dec '25 revenue of ₹ 44.84 crore. This represent the growth of 9.23% The revenue of Pentokey Organy (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ -2.01 crore. This represent the decline of -100% The ebitda of Jenburkt Pharmaceuticals Ltd for the Mar '26 is ₹ 14.65 crore as compare to the Dec '25 ebitda of ₹ 9.24 crore. This represent the growth of 58.55% The ebitda of Pentokey Organy (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -0.29 crore. This represent the decline of -100% The net profit of Jenburkt Pharmaceuticals Ltd changed from ₹ 7.42 crore to ₹ 10.85 crore over 8 quarters. This represents a CAGR of 20.92% The net profit of Pentokey Organy (India) Ltd changed from ₹ 0.05 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jenburkt Pharmaceuticals Ltd changed from 28.37 % on March 2021 to 24.76 % on March 2025 . This represents a CAGR of -2.69% over 5 yearsThe Dividend Payout of Pentokey Organy (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

About Pentokey Organy (India) Ltd

Pentokey Organy (India) Limited was incorporated on November 26, 1986.
The Company is engaged in the trading of Pharmaceutical products such as Acetic Acid, Ethyl Acetate and Acetaldehyde.
Ethyl Acetate is preferred by customers in all markets as it is fast replacing the petroleum-based solvents such as Toluene, MEK (Methyl Ethyl Ketone), MIBK (Methyl Iso Butyl Ketone) etc. In 2012-13, the production of intermediate product namely Acetic Acid was not competitive due to market prices.
Company therefore purchased the Acetic Acid from market instead of producing the same from Ethanol or Acetaldehyde.
As a result of this, production of Acetaldehyde, which is an intermediate product for Acetic Acid, was low.

FAQs for the comparison of Jenburkt Pharmaceuticals Ltd and Pentokey Organy (India) Ltd

Which company has a larger market capitalization, Jenburkt Pharmaceuticals Ltd or Pentokey Organy (India) Ltd?

Market cap of Jenburkt Pharmaceuticals Ltd is 507 Cr while Market cap of Pentokey Organy (India) Ltd is 25 Cr

What are the key factors driving the stock performance of Jenburkt Pharmaceuticals Ltd and Pentokey Organy (India) Ltd?

The stock performance of Jenburkt Pharmaceuticals Ltd and Pentokey Organy (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jenburkt Pharmaceuticals Ltd and Pentokey Organy (India) Ltd?

As of May 6, 2026, the Jenburkt Pharmaceuticals Ltd stock price is INR ₹1150.9. On the other hand, Pentokey Organy (India) Ltd stock price is INR ₹41.07.

How do dividend payouts of Jenburkt Pharmaceuticals Ltd and Pentokey Organy (India) Ltd compare?

To compare the dividend payouts of Jenburkt Pharmaceuticals Ltd and Pentokey Organy (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.